Cargando…
Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital
The global explosion of COVID-19 necessitated the rapid dissemination of information regarding SARS-CoV-2. Hence, COVID-19 prevalence and outcome data in Parkinson's disease patients were disseminated at a time when we only had part of the picture. In this chapter we firstly discuss the current...
Autores principales: | Fearon, Conor, Fasano, Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020798/ https://www.ncbi.nlm.nih.gov/pubmed/36208906 http://dx.doi.org/10.1016/bs.irn.2022.03.001 |
Ejemplares similares
-
Parkinson’s Disease and the COVID-19 Pandemic
por: Fearon, Conor, et al.
Publicado: (2021) -
Predictors of COVID-19 outcome in Parkinson's disease
por: Fasano, Alfonso, et al.
Publicado: (2020) -
Healthcare Differences and COVID‐19 Impact on Parkinson's Disease
por: Rodríguez‐Quiroga, Sergio, et al.
Publicado: (2022) -
Punding in Parkinson's Disease: An Update
por: Rajalingam, Rajasumi, et al.
Publicado: (2023) -
COVID-19 in Parkinson's disease: Report on prevalence and outcome
por: Artusi, Carlo Alberto, et al.
Publicado: (2020)